Welcome to KAHR Medical
The mission at KAHR Medical is to develop novel fusion protein pharmaceuticals for the treatment of cancer and autoimmune diseases.
The company's drug development pipeline is built around 'trans signal converter proteins (TSCP)' - a unique class of multi-functional therapeutic agents that convert signals sent from one cell to another. Read More... |
  Animated clip: TSCP technology in autoimmune |
|
|
News & Events
Globes, Israel's premier business newspaper, presents a video web report on KAHR Medical. (View the report's English version on Utube)
|
